Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: hoffy who wrote (267)	2/11/1999 7:42:00 PM
From: QuietWon	Read Replies (2) \| Respond to of 2515

Thx, hoffy. Been trying to tell ppl that but they don't liste. Ppl, read hoffy's msg

To: hoffy who wrote (267)	2/12/1999 12:48:00 PM
From: 5,17,37,5,101,...	Read Replies (3) \| Respond to of 2515

So how can MM keep price down AND buy all they can I'd like to know what ECON law of supply and demand this follows? Investor demand heavy, right? MM demand heavy right? And price goes down? I think something fishy with your reasoning and something fishy with this stock. FIRST, this news from the conference is NOT new, but old. We all knew PIII coming soon with big partners. We all knew insiders optimistic for last three years. We all knew 100% success with head and neck with NO side effects. What gives here? A competing drug or rotten apple at IMCL they do not want to tell us about. I am long now, but lightened up above $10. Below $8 we see buying; above $10 we see selling...simple as that. I think if all is good at IMCL and no competing drug to worry us, then what is really happening is investors are skeptical of biotech in general and waiting for proof positive. This rationale I'm a little skeptical of though because if all is great at IMCL you KNOW word gets out, and price starts moving long before public gets any news to sink teeth into. Long but confused and smelling a rat, Jackson